Press Releases

Read our latest announcements

Filter by year:

Modus Therapeutics – Phase II study with sevuparin for the treatment of severe malaria initiated

Modus Therapeutics today announces that the company has approval from the regulatory authority in India to start a Phase II study with sevuparin.

View Press Release